Long-term follow-up of pediatric kidney recipients who received alemtuzumab induction [abstract]. Harriman D, Chen A, Rogers J, Stratta R, Orlando G, South A, Lin JJ, Farney A.. Am J Transplant. 2018;18(Suppl 4):702.
Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: a multicenter Midwest Pediatric Nephrology Consortium study. Kizilbash S, Claes D, Ashoor I, Chen A, Jandeska S, Matar RB, Misurac J, Sherbotie J, Twombley K, Verghese P.. Pediatr Transplant. 2017;21(3):e12873.
Severe intellectual disability is not a contraindication to kidney transplantation in children. Chen A, Farney A, Russell GB, Nicolotti L, Stratta R, Rogers J, Lin JJ.. Pediatr Transplant. 2017;21(3):e12887.
Is MEST score a risk predictor in pediatric Henoch-Schonlein purpura nephritis? [abstract]. Chen A, Goldstein DP, Voigt M, South AM, Lin J-J.. J Am Soc Nephrol. 2017;28(Abstract Suppl):750.
Vitamin D in incident nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study. Selewski DT, Chen A, Shatat IF, Pais P, Greenbaum LA, Geier P, Nelson RD, Kiessling SG, Brophy PD, Quiroga A, Seifert ME, Straatmann CE, Mahan JD, Ferris ME, Troost JP, Gipson DS.. Pediatr Nephrol. 2016;31(3):465-472.
Alemtuzumab vs antithymocyte globulin induction in pediatric renal transplant recipients: our single-center experience with 3 year follow-up [abstract]. Chen A, Farney A, Hart L, Doares W, Spainhour L, Kaczmorski S, Stratta R, Lin J.. Am J Transplant. 2013;13(Suppl 5):448.
Alemtuzumab vs antithymocyte globulin as induction in pediatric renal transplantation [abstract]. Chen A, Farney A, Hart L, Doares W, Spainhour L, Kaczmorski S, Stratta R, Lin J.. Pediatr Transplant. 2013;17(Suppl 1):56-57.
Does allograft failure impact infection risk on peritoneal dialysis: a North American Pediatric Renal Trials and Collaborative Studies Study. Chen A, Martz K, Rao PS.. Clin J Am Soc Nephrol. 2012;7(1):153-157.
Does allograft failure impact school attendance in children? A NAPRTCS study. Chen A, Martz K, Rao P.. Nephrol Dial Transplant. 2012;27(4):1682-1685.
Alemtuzumab versus antithymocyte globulin as induction in pediatric renal transplantation: our single-center experience [abstract]. Chen A, Farney A, Hart L, Doares W, Spainhour L, Kaczmorski S, Stratta R, Rogers J, Lin J-J.. Am J Transplant. 2012;12(Suppl 3):316-317.
Infectious complications in pediatric renal transplant recipients who received alemtuzumab or rabbit anti-thymocyte globulin induction [abstract]. Doares W, Chen A, Lin J-J, Hart L, Spainhour L, Kaczmorski S, Rogers J, Stratta R, Farney A.. Am J Transplant. 2012;12(Suppl 3):440-441.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.
Associate Professor, Pediatrics
Kidney Transplantation, Pediatric Nephrology, Acute Kidney Injury, Dialysis
The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.
Very knowledgeable & sweet. Upfront but courteous & caring. Extremely impressed with her.
awesome doctor and very thoughtful
great physician very good bedside interaction
Dr. Chen is simply amazing. She has helped my son and been so good to email me when I have concerns about medications or issues with him. Very timely. Very knowledgeable. A true God-send in our lives. I sing her praises to everyone I come in contact with. (I actually made a post after our clinic visit that had a picture of her with my son and several people commented that Dr. Chen had helped their kids and how much they loved her too)!! She is a total asset the Nephrology and Brenner's.